128 related articles for article (PubMed ID: 21133343)
1. Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase.
Thangapandian S; John S; Sakkiah S; Lee KW
J Chem Inf Model; 2011 Jan; 51(1):33-44. PubMed ID: 21133343
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
Appiah-Kubi P; Soliman M
Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.
Thangapandian S; John S; Sakkiah S; Lee KW
Eur J Med Chem; 2011 May; 46(5):1593-603. PubMed ID: 21377770
[TBL] [Abstract][Full Text] [Related]
4. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.
Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA
Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design.
Thangapandian S; John S; Arooj M; Lee KW
PLoS One; 2012; 7(4):e34593. PubMed ID: 22496831
[TBL] [Abstract][Full Text] [Related]
6. Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors.
Thangapandian S; John S; Son M; Arulalapperumal V; Lee KW
Future Med Chem; 2013 Jan; 5(1):27-40. PubMed ID: 23256811
[TBL] [Abstract][Full Text] [Related]
7. QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors.
Sonawane LV; Bari SB
Yao Xue Xue Bao; 2010 May; 45(5):615-23. PubMed ID: 20931764
[TBL] [Abstract][Full Text] [Related]
8. Pre-steady-state kinetic characterization of thiolate anion formation in human leukotriene C₄ synthase.
Rinaldo-Matthis A; Ahmad S; Wetterholm A; Lachmann P; Morgenstern R; Haeggström JZ
Biochemistry; 2012 Jan; 51(4):848-56. PubMed ID: 22217203
[TBL] [Abstract][Full Text] [Related]
9. Human melanoma cells generate leukotrienes B4 and C4 from leukotriene A4.
Okano-Mitani H; Ikai K; Imamura S
Arch Dermatol Res; 1997 May; 289(6):347-51. PubMed ID: 9209681
[TBL] [Abstract][Full Text] [Related]
10. 14,15-Dehydroleukotriene A4: a specific substrate for leukotriene C4 synthase.
Sala A; Garcia M; Zarini S; Rossi JC; Folco G; Durand T
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):225-9. PubMed ID: 9359857
[TBL] [Abstract][Full Text] [Related]
11. In silico modeling of the molecular structure and binding of leukotriene A4 into leukotriene A4 hydrolase.
Paz PB; Vega-Hissi EG; Estrada MR; Garro Martinez JC
Chem Biol Drug Des; 2012 Dec; 80(6):902-8. PubMed ID: 22913921
[TBL] [Abstract][Full Text] [Related]
12. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
[TBL] [Abstract][Full Text] [Related]
13. Studies of leukotriene A4-hydrolase and leukotriene C4-synthase in human endothelial cells: enzymes involved in the metabolism of monocyte released leukotriene A4.
Claesson HE; Johnson HA; Rådmark O; Jakobsson PJ
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():663-6. PubMed ID: 1847569
[No Abstract] [Full Text] [Related]
14. Studies on the active site of leukotriene A4 hydrolase.
Wetterholm A; Mueller MJ; Blomster M; Samuelsson B; Haeggström JZ
Adv Exp Med Biol; 1997; 407():1-7. PubMed ID: 9321924
[No Abstract] [Full Text] [Related]
15. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
Appiah-Kubi P; Soliman ME
J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators.
Tripathi N; Paliwal S; Sharma S; Verma K; Gururani R; Tiwari A; Verma A; Chauhan M; Singh A; Kumar D; Pant A
Sci Rep; 2018 Oct; 8(1):14604. PubMed ID: 30279487
[TBL] [Abstract][Full Text] [Related]
17. High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors.
Muthusamy K; Singh KhD; Chinnasamy S; Nagamani S; Krishnasamy G; Thiyagarajan C; Premkumar P; Anusuyadevi M
Interdiscip Sci; 2013 Jun; 5(2):119-26. PubMed ID: 23740393
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
[TBL] [Abstract][Full Text] [Related]
19. Tandem Benzophenone Amino Pyridines, Potent and Selective Inhibitors of Human Leukotriene C4 Synthase.
Kleinschmidt TK; Haraldsson M; Basavarajappa D; Lundeberg E; Thulasingam M; Ekoff M; Fauland A; Lehmann C; Kahnt AS; Lindbom L; Haeggström JZ
J Pharmacol Exp Ther; 2015 Oct; 355(1):108-16. PubMed ID: 26283693
[TBL] [Abstract][Full Text] [Related]
20. [Effect of alpha-tocopherol, tocopheryl quinone and other complexes with tocopherol-binding proteins on the activity of enzymes metabolizing arachidonic acid].
Parkhomets' VP; Silonov SB; Donchenko HV
Ukr Biokhim Zh (1999); 2001; 73(1):43-7. PubMed ID: 11599425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
